clinical and laboratory manifestations of thrombocytopenia in patients with systemic lupus erythematosus

Authors

i. salehi.

akbarian.

akbarian.

f. shahram.

abstract

in systemic lupus erythematosus- (sle) various antibodies are produced against cells including platelets and result in thrombocytopenia. in the literature, the incidence of thrombocytopenia varied from 7% to 52%, in seven series of sle patients with a mean cumulative percentage of 14.5% (1-5). sle patients referred to the lupus unit of the rheumatology research center, tehran university for medical sciences (shariati hospital) during the period of 1975 to 1977 were included in this study. t/irombocytopenic patients were selected and 72 items were studied. tiie incidence of thrombocytopenia in iranian sle patients was 16.6%, which is similar to the mean cumulative percentage mentioned above. there was no difference in sex ratio between thrombocytopenic ami nonthrombocytopenic patients: tiie same was true for the mean age at the onset of the disease. in 70% of patients there was mild to moderate thrombocytopenia (platelet from 50000 to ls0000/mm3). the remaining (30%) had severe to very severe thrombocytopenia. in 1.9% of patients had a previous diagnosis of idiopathic thrombocytopenic purpura (itp). the following symptoms were seen more oflen in thrombocy¬topenic patients than in others: hemolytic anemia (p 700, positive fana, positive anti-dsdna antibodies, positive vdrl, and positive anticardiolipin antibodies. all thrombocytopenic patients' except one (previously sptenectomized) were controlled by the medical treatment. severe and very severe thrombocytopenia were controlled in 86% of cases by moderate to high dose steroids, with or without cytotoxic drugs: in 10% of cases, thrombocytopenia was controlled by a combination of chloroquine and low dose steroid (< 15 mg prednisolone daily). in 4%, other medical treatments (danazol, etc.) were needed.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Large Ovarian Hemorrhagic Cyst and Immune Thrombocytopenia as Early Manifestations of Systemic Lupus Erythematosus (SLE)

Hematologic abnormali"es are generally present among systemic lupus erythematosus pa"ents. Idiopathic thrombocytopenic purpura can be the first manifesta"on of SLE, followed by other symptoms and signs of disease appearing several years later. Although bleeding due to immune thrombocytopenic purpura is usually mild and occurs in mucocutaneous surfaces, but it may be severe and represent in u...

full text

Codon 72 Polymorphism of p53 Gene and Hematologic Manifestations in Patients with Systemic Lupus Erythematosus

Background: Systemic lupus erythematosus is a systemic autoimmune disorder with unclear etiology. The importance of some genes in the development of systemic lupus erythematosus has been implicated. The gene polymorphism in codon 72 has attracted a lot of attention and its role in the occurrence or progression of many cancers and autoimmune diseases especially systemic lupus erythematosus has ...

full text

Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus in Pakistani Lupus Patients

Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by the presence of autoantibodies. These antibodies bind to circulating antigens to form immune complexes that get deposit on the tissue and bring about the symptoms of SLE. The main objectives of this study were to enlighten the clinical manifestations common in Pakistani SLE patients; to quantify the wide range of serum...

full text

Cutaneous Manifestations of Systemic Lupus Erythematosus in Iranian Children

Systemic lupus erythematous (SLE) is an autoimmune process in which cutaneous lesions occur in majority of patients. This study was conducted to determine the pattern and prevalence of such lesions in SLE in Iranian children infected with SLE. Forty-eight patients, age between 3-16 yrs and male to female ratio of 7/1 were examined for the presence of cutaneous manifestations of SLE. The most co...

full text

A review on the latest clinical and laboratory criteria for clinical diagnosis of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with various organs involvement which early diagnosis of disease is critical for successful treatment. The subjects with the possibility of SLE who visit by physician, their full medical history and specific immunological tests should investigate precisely in order to subsequently asses their hematological and renal parameters t...

full text

Cutaneous manifestations of systemic Lupus Erythematosus: A study from Ahwaz

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease in which cutaneous lesions occur in 72%-85% of patients. Objective: This study was conducted to determine the pattern and incidence of skin lesions in SLE patients in Ahwaz. Patients and Methods: Thirty patients with SLE fulfilling the clinical and laboratory criteria of the American Rheumatism Association who were admitted...

full text

My Resources

Save resource for easier access later


Journal title:
acta medica iranica

جلد ۳۵، شماره ۱-۲، صفحات ۸-۱۰

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023